Yang Gong, Rosen Daniel G, Mercado-Uribe Imelda, Colacino Justin A, Mills Gordon B, Bast Robert C, Zhou Chenyi, Liu Jinsong
Department of Pathology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA.
Carcinogenesis. 2007 Jan;28(1):174-82. doi: 10.1093/carcin/bgl115. Epub 2006 Jul 8.
Ovarian cancer is developed from a single layer of thin epithelial cells covering the surface of ovary, named human ovarian surface epithelial cells. Like all primary human cells, human ovarian surface epithelial cells have a finite life span and will go into senescence and eventually die when cultured in vitro. Immortalized human ovarian surface epithelial cells will provide an important model system with which to study ovarian cancer initiation and progression. Here, we show that silencing p53 expression with retrovirus-mediated small interfering RNA can delay the senescence and extend cell passage number, but is not sufficient to immortalize normal ovarian surface epithelial cells. Introduction of the catalytic subunit of telomerase is similarly insufficient to achieve immortalization. However, concurrent disruption of p53 expression with small interfering RNA retroviral constructs and ectopic expression of the catalytic subunit of telomerase was sufficient to induce cellular immortalization in 3 of 3 human ovarian surface epithelial cell cultures tested. The immortalization is associated with increased telomerase activity and telomere length, and attenuated response of cell-cycle regulatory proteins to irradiation. The resultant immortal cells continued to express the same specific cytokeratins 8 and 18 as parental cells did, indicating that the epithelial characters are still maintained in the immortal cells. In addition, the immortalized cells are non-tumorigenic and nearly diploid, which is in constrast with one immortalized by SV40 T/t antigens and hTERT. As both p53 pathway dysfunction and activation of telomerase are commonly present in human ovarian cancer, these immortal cells provide an authetic cell model system for the study of the human ovarian cancer initiation, progression, differentiation and chemoprevention.
卵巢癌由覆盖卵巢表面的单层薄上皮细胞发展而来,这些细胞被称为人卵巢表面上皮细胞。与所有原代人类细胞一样,人卵巢表面上皮细胞具有有限的寿命,在体外培养时会进入衰老并最终死亡。永生化的人卵巢表面上皮细胞将为研究卵巢癌的发生和发展提供一个重要的模型系统。在此,我们表明,用逆转录病毒介导的小干扰RNA沉默p53表达可延缓衰老并增加细胞传代次数,但不足以使正常卵巢表面上皮细胞永生化。引入端粒酶催化亚基同样不足以实现永生化。然而,用小干扰RNA逆转录病毒构建体同时破坏p53表达并异位表达端粒酶催化亚基,足以在测试的3个人卵巢表面上皮细胞培养物中的3个中诱导细胞永生化。永生化与端粒酶活性增加和端粒长度增加以及细胞周期调节蛋白对辐射的反应减弱有关。所得的永生化细胞继续表达与亲代细胞相同的特异性细胞角蛋白8和18,表明永生化细胞仍保持上皮特征。此外,永生化细胞无致瘤性且近乎二倍体,这与由SV40 T/t抗原和hTERT永生化的细胞形成对比。由于p53途径功能障碍和端粒酶激活在人卵巢癌中普遍存在,这些永生化细胞为研究人卵巢癌的发生、发展、分化和化学预防提供了一个真实的细胞模型系统。